SEC ownership of Brainsway Ltd.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001505065.

Comparable stake leader

Valor BrainsWay Holdings, LLC

Disclosed value leader

Valor BrainsWay Holdings, LLC

Comparable rows

50/50

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Valor BrainsWay Holdings, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001505065
Issuer location
Jerusalem, Israel

Ownership snapshot

Top shareholders of Brainsway Ltd. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Valor BrainsWay Holdings,...
Disclosed value leader
Valor BrainsWay Holdings,...
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G 13F Lead comparable stake: 15% 13D/G row: Valor BrainsWay Holdings, LLC Showing 1-8 of 50 holder rows.

Quick read

Valor BrainsWay Holdings, LLC leads the comparable SEC ownership view at 15%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Valor BrainsWay Holdings, LLC's linked filing trail.
Comparable ownership Top 5
Valor BrainsWay Holdings, LLC 15%
Harel Insurance Investments & Fin... 8.3%
MEITAV INVESTMENT HOUSE LTD 6.3%
Avner Hagai 4.7%
Valor Management LLC 14%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Valor BrainsWay Holdings, LLC
13D/G
Jonathan Shulkin
15%
$88,184,187
5,851,444 shares
-$28,521,524 06 Oct 2025
Harel Insurance Investments & Financial Services Ltd.
13D/G 13F
Company
8.3%
$50,643,369
3,265,397 shares
+$9,123,693 30 Jun 2026
MEITAV INVESTMENT HOUSE LTD
13D/G
6.3%
$42,391,572
2,532,352 shares
+$7,243,649 01 Jun 2026
Avner Hagai
13D/G
4.7%
$16,784,164
1,772,351 shares
$0 28 Jan 2025
Valor Management LLC
13F
Company
13F
14%
$82,434,875
5,314,950 shares
30 Jun 2026
MASTERS CAPITAL MANAGEMENT LLC
13F
Company
13F
3.8%
$23,265,000
1,500,000 shares
30 Jun 2026
ACADIAN ASSET MANAGEMENT LLC
13F
Company
13F
2.1%
$12,514,000
807,931 shares
30 Jun 2026
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
13F
1.5%
$9,191,319
592,606 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 19 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-13 of 13 reporting-owner rows connected to Brainsway Ltd.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
13
Largest Forms 3/4/5 holder
Jonathan K. Shulkin
Net 12M change
$0
Latest report
01 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Jonathan K. Shulkin Director Mixed 18 Mar 2026
Gilad Moiseyev Chief Technology Officer Mixed 25 May 2026
Amiram Boehm Director Mixed 18 Mar 2026
Colleen Hanlon VP of Medical Affairs Mixed 18 Mar 2026
Hadar Levy Chief Executive Officer Mixed 18 Mar 2026
Naomi Rozenfeld Chief Marketing Officer Mixed 18 Mar 2026
Avner Lushi Director Mixed 18 Mar 2026
Karen Sarid Director Mixed 18 Mar 2026
Ido Marom Chief Financial Officer Mixed 18 Mar 2026
Yiftach Roth Chief Scientist Mixed 01 Jun 2026
David Zacut Director Mixed 18 Mar 2026
Abraham Zangen Director Mixed 18 Mar 2026
Rayten Michal Ety Mitrany Director Mixed 25 May 2026

Recent insider transactions for Brainsway Ltd.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Gilad Moiseyev BWAY Ordinary Shares Sale -8.61% -5,000 53,098 15 Jun 2026 Direct
Yiftach Roth BWAY Ordinary Shares Sale -0.28% -3,000 1,072,305 02 Jun 2026 Direct
Yiftach Roth BWAY Ordinary Shares Sale -0.37% -4,000 1,075,305 01 Jun 2026 Direct
Rayten Michal Ety Mitrany BWAY Ordinary Shares Sale -39% -7,980 12,500 26 May 2026 Direct
Gilad Moiseyev BWAY Ordinary Shares Tax liability -3.17% -1,902 58,098 25 May 2026 Direct
Gilad Moiseyev BWAY Ordinary Shares Options Exercise 14.3% 7,500 60,000 25 May 2026 Direct
Gilad Moiseyev BWAY Stock Options (right to buy) Options Exercise -25% -7,500 22,500 25 May 2026 Direct
Rayten Michal Ety Mitrany BWAY Ordinary Shares Sale -32.8% -10,000 20,480 25 May 2026 Direct
Rayten Michal Ety Mitrany BWAY Ordinary Shares Tax liability -16.6% -6,080 30,480 20 May 2026 Direct
Rayten Michal Ety Mitrany BWAY Ordinary Shares Options Exercise 91.8% 17,500 36,560 20 May 2026 Direct
Rayten Michal Ety Mitrany BWAY Stock Options (right to buy) Options Exercise -100% -17,500 0 20 May 2026 Direct
Rayten Michal Ety Mitrany BWAY Ordinary Shares Tax liability -15.3% -3,440 19,060 19 May 2026 Direct
Rayten Michal Ety Mitrany BWAY Ordinary Shares Options Exercise 80% 10,000 22,500 19 May 2026 Direct
Rayten Michal Ety Mitrany BWAY Stock Options (right to buy) Options Exercise -36.4% -10,000 17,500 19 May 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .